Rational Design, Synthesis and Evaluation of Novel Rodanine Derivatives for Antihyperglycemic Activity

References

• R. Dumpati, R. Dulapalli, B. Kondagari, V. Ramatenki, S. Vellanki, R. Vadija, and U. Vuruputuri, “Suppressor of Cytokine Signalling-3 as a Drug Target for Type 2 Diabetes Mellitus: A Structure-Guided Approach,” ChemistrySelect 1, no. 10 (2016): 2502–14.
   Web of Science ®Google Scholar
• T. Scully, “Diabetes in Number,” Nature 485, no. 7398 (2012): S2–S2.
   PubMedGoogle Scholar
• Y. Jia, J.-Y. Kim, H.-J. Jun, S.-J. Kim, J.-H. Lee, M. H. Hoang, K.-Y. Hwang, S.-J. Um, H. I. Chang, S.-J. Lee, et al. “The Natural Carotenoid Astaxanthin, a PPAR-α Agonist and PPAR-γ Antagonist, Reduces Hepatic Lipid Accumulation by Rewiring the Transcriptome in Lipid-Loaded Hepatocytes,” Molecular Nutrition & Food Research 56, no. 6 (2012): 878–88.
   PubMed Web of Science ®Google Scholar
• M. Le Naour, V. Leclerc, A. Farce, D.-H. Caignard, N. Hennuyer, B. Staels, V. Audinot-Bouchez, J.-A. Boutin, M. Lonchampt, C. Dacquet, et al. “Effect of Oxime Ether Incorporation in Acyl Indole Derivatives on PPAR Subtype Selectivity,” ChemMedChem 7, no. 12 (2012): 2179–93.
   PubMed Web of Science ®Google Scholar
• R. K. Chaturvedi, and M. F. Beal, “PPAR: A Therapeutic Target in Parkinson’s disease,” Journal of Neurochemistry 106, no. 2 (2008): 506–18.
   PubMed Web of Science ®Google Scholar
• U. Grether, W. Klaus, B. Kuhn, H. P. Maerki, P. Mohr, and M. B. Wright, “New Insights on the Mechanism of PPAR-Targeted Drugs,” ChemMedChem 5, no. 12 (2010): 1973–6.
   PubMed Web of Science ®Google Scholar
• A. B. Jones, “Peroxisome Proliferator-Activated Receptor (PPAR) Modulators: Diabetes and beyond,” Medicinal Research Reviews 21, no. 6 (2001): 540–52.
   PubMed Web of Science ®Google Scholar
• H. Xie, Y. Li, F. Yu, X. Xie, K. Qiu, and J. Fu, “An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors,” International Journal of Molecular Sciences 16, no. 11 (2015): 27350–61.
   PubMed Web of Science ®Google Scholar
• S. K. Gupta, S. Singh, A. Nischal, K. K. Pant, and P. K. Seth, “Molecular Docking and Simulation Studies towards Exploring Antiviral Compounds against Envelope Protein of Japanese Encephalitis Virus,” Network Modeling Analysis in Health Informatics and Bioinformatics 2, no. 4 (2013): 231–43.
   Google Scholar
• S. P. Mandal, A. Garg, P. Prabitha, A. D. Wadhwani, L. Adhikary, and B. R. P. Kumar, “Novel Glitazones as PPARγ Agonists: molecular Design, Synthesis, Glucose Uptake Activity and 3D QSAR Studies,” Chemistry Central Journal 12, no. 1 (2018): 141.
   PubMedGoogle Scholar
• T. Makarewicz, and R. Kaźmierkiewicz, “Molecular Dynamics Simulation by GROMACS Using GUI Plugin for PyMOL,” Journal of Chemical Information and Modeling 53, no. 5 (2013): 1229–34.
   PubMed Web of Science ®Google Scholar
• A. T. Odularu, and P. A. Ajibade, “Dithiocarbamates: Challenges, Control, and Approaches to Excellent Yield, Characterization, and Their Biological Applications,” Bioinorganic Chemistry and Applications 2019 (2019): 1–15.
   Web of Science ®Google Scholar
• H. Andleeb, Y. Tehseen, S. J. Ali Shah, I. Khan, J. Iqbal, and S. Hameed, “Identification of Novel Pyrazole-Rhodanine Hybrid Scaffolds as Potent Inhibitors of Aldose Reductase: Design, Synthesis, Biological Evaluation and Molecular Docking Analysis,” RSC Advances 6, no. 81 (2016): 77688–700.
   Web of Science ®Google Scholar
• L. Dinparast, S. Hemmati, G. Zengin, A. A. Alizadeh, M. B. Bahadori, H. S. Kafil, and S. Dastmalchi, “Rapid, Efficient, and Green Synthesis of Coumarin Derivatives via Knoevenagel Condensation and Investigating Their Biological Effects,” ChemistrySelect 4, no. 31 (2019): 9211–5.
   Web of Science ®Google Scholar
• A. Alizadeh, S. Rostamnia, N. Zohreh, and R. Hosseinpour, “A Simple and Effective Approach to the Synthesis of Rhodanine Derivatives via Three-Component Reactions in Water,” Tetrahedron Letters 50, no. 14 (2009): 1533–5.
   Web of Science ®Google Scholar
• H. Andleeb, I. Khan, A. Bauzá, M. N. Tahir, J. Simpson, S. Hameed, and A. Frontera, “Synthesis and Supramolecular Self-Assembly of Thioxothiazolidinone Derivatives Driven by H-Bonding and Diverse π–Hole Interactions: A Combined Experimental and Theoretical Analysis,” Journal of Molecular Structure 1139 (2017): 209–21.
   Web of Science ®Google Scholar
• M. Suzuki, H. Kojima, T. Nakano, A. Kashiwagi, H. Hidaka, K. Kosugi, Y. Shigeta, and Y. Harano, “In Vitro Stimulation of Glucose Utilization by Insulin in Primary Cultures of Rat Hepatocytes,” Diabetes Research and Clinical Practice 13, no. 3 (1991): 163–72.
   PubMed Web of Science ®Google Scholar
• S. R. Nagarajan, M. Paul-Heng, J. R. Krycer, D. J. Fazakarley, A. F. Sharland, and A. Hoy, “Lipid and Glucose Metabolism in Hepatocyte Cell Lines and Primary Mouse Hepatocytes: A Comprehensive Resource for in Vitro Studies of Hepatic Metabolism,” The American Journal of Physiology-Endocrinology and Metabolism 316 (2019): 578–89.
   Web of Science ®Google Scholar
• J. R. Cook, F. Langlet, Y. Kido, and D. Accili, “Pathogenesis of Selective Insulin Resistance in Isolated Hepatocytes,” The Journal of Biological Chemistry 290, no. 22 (2015): 13972–80.
   PubMed Web of Science ®Google Scholar
• B. R. P. Kumar, T. K. Praveen, M. J. Nanjan, M. D. Karvekar, and B. Suresh, “Serum Glucose and Triglyceride Lowering Activity of Some Novel Glitazones against Dexamethasone-Induced Hyperlipidemia and Insulin Resistance,” Indian Journal of Pharmacology 39, no. 6 (2007): 299–302.
   Web of Science ®Google Scholar
• Q.-Q. Yin, J.-J. Pei, S. Xu, D.-Z. Luo, S.-Q. Dong, M.-H. Sun, L. You, Z.-J. Sun, and X.-P. Liu, “Pioglitazone Improves Cognitive Function via Increasing Insulin Sensitivity and Strengthening Antioxidant Defense System in Fructose-Drinking Insulin Resistance Rats,” PLoS One 8, no. 3 (2013): e59313.
   PubMed Web of Science ®Google Scholar